Home › Onxeo S.A.: Phase II trial results of Validive presented at the ASCO Conference
 

Keywords :   


Onxeo S.A.: Phase II trial results of Validive presented at the ASCO Conference

2015-04-02 18:23:24| Logistics - Topix.net

Regulatory News: Onxeo S.A. , an innovative company specializing in the development of orphan oncology drugs, today announced that Validive phase II clinical trial results have been accepted for a poster presentation at the 2015 Annual Meeting of the American Society of Clinical Oncology . The ASCO annual meeting is a major event in the field of oncology that brings together 30,000 health professionals and updates on the major latest steps and results achieved in oncology worldwide.

Tags: the results presented trial

Category:Transportation and Logistics

Latest from this category

All news
16.11Eastern North Pacific Tropical Weather Outlook
16.11Atlantic Tropical Weather Outlook
16.11Tropical Storm Sara Graphics
16.11Summary for Tropical Storm Sara (AT4/AL192024)
16.11Tropical Storm Sara Public Advisory Number 9A
15.11Tropical Storm Sara Forecast Discussion Number 9
15.11Tropical Storm Sara Wind Speed Probabilities Number 9
15.11Summary for Tropical Storm Sara (AT4/AL192024)
Transportation and Logistics »
16.11 onecontrol Chamaeleo Tail Loop MKII
16.11ZIGGY ORDER-MADE
16.116
16.11SwitchCoLotta
16.11 p8
16.11mtg foil 3
16.11RolandSP-404SX
16.11DVD 42
More »